Insilico's AI-designed fibrosis drug cuts predicted biological age by ~3 years
Polymarket · x · 2026-09-09
Insilico Medicine says its AI-designed fibrosis drug produced an average 3-year drop in predicted biological age among participants, prompting the company to claim "we might have a chance to stop biological aging." Details on sample size and mechanism are not yet disclosed.
Related event: Insilico's AI-designed drug appears to slow biological aging(2 posts)→
More from Research
- Researchers identify "Forking": train loss falls while validation loss turns up — ZimingLiu11 · 2026-10-26
- Google DeepMind pilots world's first double-blind evaluations for frontier models — scychan_brains · 2026-10-26
- Rewriting scaling law study: optimal synthetic data share rises from 10% to 32% with compute — heghbalz · 2026-10-26
- FLASH: GPU-native deformable sim learns cloth folding in minutes on one RTX 5090 — ChongZzZhang · 2026-10-26
- LEMON: zero-shot LLM misbehavior monitor flags hallucinations from attention maps — yoavartzi · 2026-10-26
- Behind the EMNLP keynote: LMs as simulated learners to generate child language acquisition hypotheses — najoungkim · 2026-10-26